Whitehawk Therapeutics (WHWK) Cash from Operations (2010 - 2026)

Whitehawk Therapeutics (WHWK) has 17 years of Cash from Operations data on file, last reported at 22208000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 87.19% year-over-year to 22208000.0 in Q1 2026; TTM through Mar 2026 was 107777000.0, a 108.22% decrease from a year earlier, with the FY2025 full-year figure at 97433000.0, down 63.62% from the prior year.
• Cash from Operations for Q1 2026 stood at 22208000.0, down from 17234000.0 in the prior quarter.
• Over the last five years, Cash from Operations for WHWK reached as high as 8195000.0 in Q3 2022 and fell as low as 52957000.0 in Q2 2025.
• Historically, Cash from Operations has averaged 16970235.29 across 5 years, with a median of 15378000.0 in 2025.
• Across the five-year window, Cash from Operations jumped 52.83% in 2022 and tumbled 478.32% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 11310000.0 in 2022, then increased by 14.73% to 9644000.0 in 2023, then plunged by 56.09% to 15053000.0 in 2024, then dropped by 14.49% to 17234000.0 in 2025, then fell by 28.86% to 22208000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 22208000.0 in Q1 2026, 17234000.0 in Q4 2025, and 15378000.0 in Q3 2025.